Copyright
©2013 Baishideng Publishing Group Co.
World J Immunol. Nov 27, 2013; 3(3): 62-67
Published online Nov 27, 2013. doi: 10.5411/wji.v3.i3.62
Published online Nov 27, 2013. doi: 10.5411/wji.v3.i3.62
HROG02 | HROG04 | HROG05 | HROG06 | HROG10 | HROG13 | HROG17 | ||||||||
HLA-A typing | *01 | *02 | *01 | *02 | *02 | - | *01 | *03 | *02 | *23 | *02 | - | *11 | *66 |
Flow cytometry (HLA-A02) | 88% ( ± 10%) | 95% ( ± 1%) | 83% ( ± 10%) | 1% ( ± 1%) | 89% ( ± 4%) | 92% ( ± 3%) | 0% ( ± 0%) |
- Citation: Mullins CS, Walter A, Schmitt M, Classen CF, Linnebacher M. Tumor antigen and MHC expression in glioma cells for immunotherapeutic interventions. World J Immunol 2013; 3(3): 62-67
- URL: https://www.wjgnet.com/2219-2824/full/v3/i3/62.htm
- DOI: https://dx.doi.org/10.5411/wji.v3.i3.62